Slingshot Biosciences
Emeryville
About Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics. The company aims to bring simple, elegant, and cost-effective solutions to common problems facing research and development programs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $64.2M
- Funding stage: Early Stage Venture
- Last round: Series A (Apr 2024)
- Website: slingshotbio.com
- Phone: +1 510-770-6806
Industries & Categories
Biotechnology, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/slingshot-biosciences-90128 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.